Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for TEM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 444.93M
March 31, 2026 416.40M
December 31, 2025 491.33M
September 30, 2025 507.82M
June 30, 2025 309.56M
March 31, 2025 326.19M
December 31, 2024 56.34M
September 30, 2024 53.73M
June 30, 2024 98.25M
March 31, 2024 -339.62M
December 31, 2023 -276.62M
September 30, 2023
Date Value
June 30, 2023
March 31, 2023
December 31, 2022 -102.88M
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021 90.80M
September 30, 2021 151.21M
June 30, 2021
March 31, 2021
December 31, 2020 346.17M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Personalis, Inc. 235.16M
10X Genomics, Inc. 825.55M
Alamar Biosciences, Inc. (California) 312.86M
IQVIA Holdings, Inc. 6.171B
Twist Bioscience Corp. 445.74M

Shareholders Equity (Quarterly) Related Metrics